L-DOPA

Clinical trials for L-DOPA explained in plain language.

Never miss a new study

Get alerted when new L-DOPA trials appear

Sign up with your email to follow new studies for L-DOPA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

Could a Parkinson's drug ease symptoms of a rare childhood brain condition?

Symptom relief Recruiting now

This study tests whether L-dopa, a drug used for Parkinson's, can improve movement and communication in children with a rare genetic disorder called CTNNB1 syndrome. The condition causes developmental delays, muscle stiffness, and trouble walking. Seven children aged 1 to 15 will…

Matched conditions: L-DOPA

Phase: NA • Sponsor: University Hospital, Montpellier • Aim: Symptom relief

Last updated Jun 27, 2026 13:00 UTC

L-DOPA

Get alerted when new L-DOPA trials appear

Could a Parkinson's drug ease symptoms of a rare childhood brain condition?